{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T12:45:48Z","timestamp":1700052348149},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":7251,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1023\/a:1008384506227","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T14:41:38Z","timestamp":1040568098000},"page":"359-362","source":"Crossref","is-referenced-by-count":16,"title":["Activity of interferon-\u03b1 in relapsed patients with diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma"],"prefix":"10.1016","volume":"11","author":[{"given":"J.O.","family":"Armitage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Coiffier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008384506227_bb0100","first-page":"36","article-title":"Recombinant interferon-\u03b1 in the treatment of lymphoma patients","volume":"6","author":"Coiffier","year":"1998","journal-title":"Rev Clin Exp Hematol"},{"key":"10.1023\/A:1008384506227_bb0105","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1182\/blood.V78.12.3133.bloodjournal78123133","article-title":"A randomized comparison of two doses of human lymphoblastoid interferon-\u03b1 in hairy cell leukemia","volume":"78","author":"Smalley","year":"1991","journal-title":"Blood"},{"key":"10.1023\/A:1008384506227_bb0110","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM199311253292203","article-title":"Recombinant interferon-\u03b12b combined with a regimen containing doxorubicin in advanced follicular lymphoma","volume":"329","author":"Solal-Celigny","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008384506227_bb0115","series-title":"Ann Intern Med","article-title":"Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sezary syndrome)","author":"Bunn","year":"1994"},{"key":"10.1023\/A:1008384506227_bb0120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2133.1999.02704.x","article-title":"Long-term follow-up in 51 patients with mycosis fungoides and Sezary syndrome treated by interferon-\u03b1","volume":"140","author":"Jumbou","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1023\/A:1008384506227_bb0125","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0190-9622(99)70351-8","article-title":"Durable loss of a malignant T-cell clone in a stage IV cutaneous T-cell lymphoma patient treated with high-dose interferon and photopheresis","volume":"41","author":"Haley","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1023\/A:1008384506227_bb0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2141.1999.01500.x","article-title":"Hairy-cell leukaemia: Biology and management","volume":"106","author":"Pettitt","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1023\/A:1008384506227_bb0135","first-page":"1517","article-title":"An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: Developed for the American Society of Hematology","volume":"94","author":"Silver","year":"1999","journal-title":"Blood"},{"key":"10.1023\/A:1008384506227_bb0140","first-page":"36","article-title":"Treatment of multiple myeloma","volume":"84","author":"San Miguel","year":"1999","journal-title":"Haematologica"},{"key":"10.1023\/A:1008384506227_bb0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00002371-199903000-00006","article-title":"Muhonen T Regimens with or without interferon-\u03b1 as treatment for metastatic melanoma and renal-cell carcinoma: An overview of randomized trials","volume":"22","author":"Hernberg","year":"1999","journal-title":"J Immunother"},{"key":"10.1023\/A:1008384506227_bb0150","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198411013111803","article-title":"Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon","volume":"311","author":"Foon","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008384506227_bb0155","first-page":"1305","article-title":"Human interferon-\u03b1 in malignant lymphoma and Hodgkin's disease","volume":"56","author":"Horning","year":"1985","journal-title":"Results of the American Cancer Society trial. Cancer"},{"key":"10.1023\/A:1008384506227_bb0160","series-title":"Semin Oncol","article-title":"Interferon-\u03b12b in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma","author":"Leavitt","year":"1987"},{"key":"10.1023\/A:1008384506227_bb0165","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting \u2013 Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008384506227_bb0170","first-page":"150","article-title":"Retinoids as antitumor agents: A new age of biological therapy","volume":"5","author":"Kurie","year":"1999","journal-title":"Cancer J Sci Am"},{"key":"10.1023\/A:1008384506227_bb0175","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM197812282992608","article-title":"Preliminary observations on the effect of human leukocyte interferon in non-Hodgin's lymphoma","volume":"299","author":"Merigan","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008384506227_bb0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00944195","article-title":"Maintenance therapy with interferon-\u03b12b in patients with diffuse large-cell lymphoma","volume":"10","author":"Aviles","year":"1992","journal-title":"Invest New Drugs"},{"key":"10.1023\/A:1008384506227_bb0185","series-title":"Preliminary results of an international randomized study on 199 patients. Blood","article-title":"Interferon-\u03b12b versus no treatment after intensive therapy and autologous stem-cell transplantation for relapsing lymphoma","author":"Bosley","year":"1999"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420315337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420315337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/11\/3\/359\/19478483\/11-3-359.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T07:39:05Z","timestamp":1582184345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420315337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S0923753420315337"],"URL":"https:\/\/doi.org\/10.1023\/a:1008384506227","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}